Mesenchymal Stem Cell Conditioned Medium Modulates Inflammation in Tenocytes: Complete Conditioned Medium Has Superior Therapeutic Efficacy than Its Extracellular Vesicle Fraction
International Journal of Molecular Sciences · 29.06.2023 · 24 (13) · 10857
DOI: 10.3390/ijms241310857 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.06.2023. Verfasst von Robert Soukup und 5 weiteren Autor:innen. Beteiligte Einrichtung: VETERM, Equine Surgery Unit, Department for Companion Animals and Horses, Vetmeduni, 1210 Vienna, Austria. Hauptthemen laut MEDLINE: Extracellular Vesicles, Mesenchymal Stem Cells. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund (FWF), Herzfelder’sche Familienstiftung.
Abstract (Originalsprache)
Tendinopathy, a prevalent overuse injury, lacks effective treatment options, leading to a significant impact on quality of life and socioeconomic burden. Mesenchymal stem/stromal cells (MSCs) and their secretome, including conditioned medium (CM) and extracellular vesicles (EVs), have shown promise in tissue regeneration and immunomodulation. However, it remains unclear which components of the secretome contribute to their therapeutic effects. This study aimed to compare the efficacy of CM, EVs, and the soluble protein fraction (PF) in treating inflamed tenocytes. CM exhibited the highest protein and particle concentrations, followed by PF and EVs. Inflammation significantly altered gene expression in tenocytes, with CM showing the most distinct separation from the inflamed control group. Treatment with CM resulted in the most significant differential gene expression, with both upregulated and downregulated genes related to inflammation and tissue regeneration. EV treatment also demonstrated a therapeutic effect, albeit to a lesser extent. These findings suggest that CM holds superior therapeutic efficacy compared with its EV fraction alone, emphasizing the importance of the complete secretome in tendon injury treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- VETERM, Equine Surgery Unit, Department for Companion Animals and Horses, Vetmeduni, 1210 Vienna, Austria.
- Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.
- Science Consult DI Thomas Mohr KG, 2353 Guntramsdorf, Austria.
- Center for Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.
- Department of Analytical Chemistry, University of Vienna, 1090 Vienna, Austria.
- Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
ORCID-Profile: Thomas Mohr, Sinan Gueltekin, Johannes Grillari, Florien Jenner
Förderung
- Austrian Science Fund FWF
- Austrian Science Fund (FWF)
- Herzfelder’sche Familienstiftung
Zitieren
APA
Soukup, R., Gerner, I., Mohr, T., Gueltekin, S., Grillari, J., & Jenner, F. (2023). Mesenchymal Stem Cell Conditioned Medium Modulates Inflammation in Tenocytes: Complete Conditioned Medium Has Superior Therapeutic Efficacy than Its Extracellular Vesicle Fraction. International Journal of Molecular Sciences, 24(13), 10857. https://doi.org/10.3390/ijms241310857
Vancouver
Soukup R, Gerner I, Mohr T, Gueltekin S, Grillari J, Jenner F. Mesenchymal Stem Cell Conditioned Medium Modulates Inflammation in Tenocytes: Complete Conditioned Medium Has Superior Therapeutic Efficacy than Its Extracellular Vesicle Fraction. International Journal of Molecular Sciences. 2023;24(13):10857. doi:10.3390/ijms241310857
BibTeX
@article{Soukup2023,
author = {Soukup, Robert and Gerner, Iris and Mohr, Thomas and Gueltekin, Sinan and Grillari, Johannes and Jenner, Florien},
title = {Mesenchymal Stem Cell Conditioned Medium Modulates Inflammation in Tenocytes: Complete Conditioned Medium Has Superior Therapeutic Efficacy than Its Extracellular Vesicle Fraction},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {13},
pages = {10857},
doi = {10.3390/ijms241310857}
}
EUVIMED